Dietary Advanced Glycation End Products and Aging

Overview

Journal Nutrients

Date 2012 Jan 19

PMID 22254007

Citations 126

Authors

Claudia Luevano-Contreras

Karen Chapman-Novakofski

Affiliations

Soon will be listed here.

Abstract

Advanced glycation end products (AGEs) are a heterogeneous, complex group of compounds that are formed when reducing sugar reacts in a non-enzymatic way with amino acids in proteins and other macromolecules. This occurs both exogenously (in food) and endogenously (in humans) with greater concentrations found in older adults. While higher AGEs occur in both healthy older adults and those with chronic diseases, research is progressing to both quantify AGEs in food and in people, and to identify mechanisms that would explain why some human tissues are damaged, and others are not. In the last twenty years, there has been increased evidence that AGEs could be implicated in the development of chronic degenerative diseases of aging, such as cardiovascular disease, Alzheimer's disease and with complications of diabetes mellitus. Results of several studies in animal models and humans show that the restriction of dietary AGEs has positive effects on wound healing, insulin resistance and cardiovascular diseases. Recently, the effect of restriction in AGEs intake has been reported to increase the lifespan in animal models. This paper will summarize the work that has been published for both food AGEs and in vivo AGEs and their relation with aging, as well as provide suggestions for future research.

Citing Articles

Dietary advanced glycation end products intake, genetic predisposition and risk of coronary heart disease: a prospective study.

He H, Zhang Y, Chen G, Xie F, Zeng N, Han R Eur J Nutr. 2025; 64(3):114.

PMID: 40063212 DOI: 10.1007/s00394-025-03632-x.

The role of AGEs in muscle ageing and sarcopenia.

Guo Z, Li H, Jiang S, Rahmati M, Su J, Yang S Bone Joint Res. 2025; 14(3):185-198.

PMID: 40036085 PMC: 11878473. DOI: 10.1302/2046-3758.143.BJR-2024-0252.R1.

Association Between Skin Autofluorescence and Coronary Heart Disease in Chinese General Population: A Cross-Sectional Study.

Wu Q, Cheng Y, Liu H, Wang Y, Li B, Mu Y J Diabetes. 2025; 17(3):e70061.

PMID: 40024885 PMC: 11872386. DOI: 10.1111/1753-0407.70061.

Gut bacterium Intestinimonas butyriciproducens improves host metabolic health: evidence from cohort and animal intervention studies.

Rampanelli E, Romp N, Troise A, Ananthasabesan J, Wu H, Gul I Microbiome. 2025; 13(1):15.

PMID: 39833973 PMC: 11744835. DOI: 10.1186/s40168-024-02002-9.

Effects of Yogic Practices Synchronized With Bandha and Kumbhaka on Biological and Psychological Factors of Aging in COVID-19-Recovered Patients: A Randomized Controlled Trial.

Kumari A, Pal A, Dada R Cureus. 2024; 16(10):e71884.

PMID: 39559592 PMC: 11573461. DOI: 10.7759/cureus.71884.

References

Choi S, Chang H, Choi S, Kim K, Cho Y, Youn T . Long-term exercise training attenuates age-related diastolic dysfunction: association of myocardial collagen cross-linking. J Korean Med Sci. 2009; 24(1):32-9. PMC: 2650965. DOI: 10.3346/jkms.2009.24.1.32. View

Garcia M, Seiquer I, Delgado-Andrade C, Galdo G, Navarro M . Intake of Maillard reaction products reduces iron bioavailability in male adolescents. Mol Nutr Food Res. 2009; 53(12):1551-60. DOI: 10.1002/mnfr.200800330. View

Bierhaus A, Humpert P, Morcos M, Wendt T, Chavakis T, Arnold B . Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl). 2005; 83(11):876-86. DOI: 10.1007/s00109-005-0688-7. View

Jakus V, Rietbrock N . Advanced glycation end-products and the progress of diabetic vascular complications. Physiol Res. 2004; 53(2):131-42. View

Diamanti-Kandarakis E, Piperi C, Korkolopoulou P, Kandaraki E, Levidou G, Papalois A . Accumulation of dietary glycotoxins in the reproductive system of normal female rats. J Mol Med (Berl). 2007; 85(12):1413-20. DOI: 10.1007/s00109-007-0246-6. View

Diamanti-Kandarakis E, Alexandraki K, Piperi C, Aessopos A, Paterakis T, Katsikis I . Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome. Metabolism. 2006; 56(1):129-34. DOI: 10.1016/j.metabol.2006.09.006. View

Faist V, Erbersdobler H . Metabolic transit and in vivo effects of melanoidins and precursor compounds deriving from the Maillard reaction. Ann Nutr Metab. 2001; 45(1):1-12. DOI: 10.1159/000046699. View

Sobenin I, Tertov V, Koschinsky T, Bunting C, Slavina E, Dedov I . Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells. Atherosclerosis. 1993; 100(1):41-54. DOI: 10.1016/0021-9150(93)90066-4. View

Schleicher E, Wagner E, Nerlich A . Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest. 1997; 99(3):457-68. PMC: 507819. DOI: 10.1172/JCI119180. View

10.

Birlouez-Aragon I, Saavedra G, Tessier F, Galinier A, Ait-Ameur L, Lacoste F . A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. Am J Clin Nutr. 2010; 91(5):1220-6. DOI: 10.3945/ajcn.2009.28737. View

11.

Ames J . Determination of N epsilon-(carboxymethyl)lysine in foods and related systems. Ann N Y Acad Sci. 2008; 1126:20-4. DOI: 10.1196/annals.1433.030. View

12.

Klein R, Laimins M, Lopes-Virella M . Isolation, characterization, and metabolism of the glycated and nonglycated subfractions of low-density lipoproteins isolated from type I diabetic patients and nondiabetic subjects. Diabetes. 1995; 44(9):1093-8. DOI: 10.2337/diab.44.9.1093. View

13.

Tessier F . The Maillard reaction in the human body. The main discoveries and factors that affect glycation. Pathol Biol (Paris). 2009; 58(3):214-9. DOI: 10.1016/j.patbio.2009.09.014. View

14.

Peppa M, Stavroulakis P, Raptis S . Advanced glycoxidation products and impaired diabetic wound healing. Wound Repair Regen. 2009; 17(4):461-72. DOI: 10.1111/j.1524-475X.2009.00518.x. View

15.

Xu B, Chibber R, Ruggiero D, Kohner E, Ritter J, Ferro A . Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products. FASEB J. 2003; 17(10):1289-91. DOI: 10.1096/fj.02-0490fje. View

16.

Kalousova M, Skrha J, Zima T . Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res. 2003; 51(6):597-604. View

17.

Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A . Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci U S A. 1994; 91(20):9441-5. PMC: 44828. DOI: 10.1073/pnas.91.20.9441. View

18.

Sims-Robinson C, Kim B, Rosko A, Feldman E . How does diabetes accelerate Alzheimer disease pathology?. Nat Rev Neurol. 2010; 6(10):551-9. PMC: 3199576. DOI: 10.1038/nrneurol.2010.130. View

19.

Cai W, He J, Zhu L, Peppa M, Lu C, Uribarri J . High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients. Circulation. 2004; 110(3):285-91. DOI: 10.1161/01.CIR.0000135587.92455.0D. View

20.

Janssen I, Shepard D, Katzmarzyk P, Roubenoff R . The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2003; 52(1):80-5. DOI: 10.1111/j.1532-5415.2004.52014.x. View